immunotox report (@iTOXreport) profile picture

Updates on immunotherapy toxicity : understand, explore and improve itoxicities management/ Stephane Champiat Medical Oncologist @champiatMD @gustaveroussy

Joined September 2016
Impact of PD-1 blockade on severity of COVID-19 in patients with lung cancers ⁦@CD_AACR⁩ ⁦@Jia_Luo⁩ cancerdiscovery.aacrjournals…
3
7
15
COVID-19 Implications for I-O Patient Management ⁦@sitcancer⁩ sitcancer.org/communities/co…
Autoimmune antibodies correlate with immune checkpoint therapy-induced toxicities ⁦@PNASNews⁩ pnas.org/content/116/44/2224…
Safety and Efficacy of Immune Checkpoint Inhibitor Therapy in Patients With HIV Infection and Advanced-Stage Cancer: A Systematic Review. ⁦@JAMAOnc⁩ jamanetwork.com/journals/jam…
Cytokines levels may help to identify patients at risk of irAEs ⁦@BrJCancer⁩ nature.com/articles/s41416-0…
6
11
New therapeutic perspectives to manage refractory immune checkpoint-related toxicities ⁦@TheLancetOncol⁩ thelancet.com/journals/lanon…
7
12
Complete response of metastatic melanoma in a patient with Crohn’s disease simultaneously receiving anti-α4β7 and anti-PD1 antibodies ⁦@sitcancer⁩ jitc.biomedcentral.com/artic…
3
Clinical characterization of colitis arising from anti-PD-1 based therapy tandfonline.com/doi/abs/10.1…
Haematological immune-related adverse events induced by anti-PD-1 or anti-PD-L1 immunotherapy: a descriptive observational study ⁦@TheLancetHaem⁩ thelancet.com/journals/lanha…
2
3
Impact of Checkpoint Inhibitor Pneumonitis on Survival in NSCLC Patients receiving Immune Checkpoint Immunotherapy ⁦@DrJNaidoo⁩ jto.org/article/S1556-0864(1…
Association of HLA-DRB1 shared epitope alleles and immune checkpoint inhibitor-induced inflammatory arthritis academic.oup.com/rheumatolog…
3
Thromboembolic Events Related to Treatment with Checkpoint Inhibitors: Report of Two Cases karger.com/Article/FullText/…
Evolution and recurrence of gastrointestinal irAEs induced by immune checkpoint inhibitors ejcancer.com/article/S0959-8…
2
4
Bilateral Vocal Cord Paralysis: Pembrolizumab-Induced Delayed-Onset Toxicity in a Patient with Lung Adenocarcinoma jto.org/article/S1556-0864(1…
1
1